Phase 2 Readout~quarter
Phase 2 Readout: evorpacept
- Drug
- evorpacept
- Indication
- HER2-positive metastatic breast cancer
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.